Whatever its future evolution—or revolution—the new field of oculomics is a force to be reckoned with.
A look ahead with Michael F. Chiang, MD.
Don't miss the EyeNet Corporate Lunches on Saturday, Sunday, and Monday.
Discover the only FDA-approved treatment for this rare disease.
See how TEPEZZA can help.
TEPEZZA is a trademark owned by or licensed to Horizon.
© 2021 Horizon Therapeutics plc P-TEP-01314 08/21
Publications for This Year's AAO
News in Review